|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Current assets: | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Short-term investments, net | ||||||||||||
| Prepaid contract research and manufacturing | ||||||||||||
| Other prepaid expenses and other current assets | ||||||||||||
| Total current assets | ||||||||||||
| Property and equipment, net | ||||||||||||
| Other assets | ||||||||||||
| Intangible asset, net | ||||||||||||
| Total Assets | ||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||
| Current liabilities: | ||||||||||||
| Accounts payable | ||||||||||||
| Accrued compensation and related expenses | ||||||||||||
| Accrued restructuring | ||||||||||||
| Accrued contract research and manufacturing | ||||||||||||
| Other accrued expenses | ||||||||||||
| Total liabilities | ||||||||||||
| Stockholders' equity: | ||||||||||||
| Preferred stock, $0.0001 par value, 5,000,000 shares authorized, no shares issued and outstanding | ||||||||||||
| Common stock, $0.0001 par value, 200,000,000 shares authorized, 78,457,126 and 78,433,916 shares issued and outstanding | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Deficit accumulated during the development stage | ||||||||||||
| Total stockholders' equity | ||||||||||||
| Total liabilities and stockholders' equity |
Loading...
